Overview
Neonatal alloimmune thrombocytopenia (NAIT) arises from maternal antibodies targeting paternal platelet antigens, leading to fetal platelet destruction and severe thrombocytopenia, often complicated by intracranial hemorrhage 13.Diagnosis
Prenatal diagnosis via ultrasound detecting intracranial hemorrhage or thrombocytopenia 4.
Perinatal platelet count assessment crucial for confirming thrombocytopenia 15.
Antenatal testing through periumbilical blood sampling for platelet counts 5.Management
First-line treatments:
- Intravenous immunoglobulin (IVIG) at high doses (1-2 g/kg weekly) 15.
- Corticosteroids as adjunctive therapy 1.
Postnatal management:
- Intravenous gamma globulin (IVGG) for treating neonatal thrombocytopenia 2.Special Populations
Pregnancy: Antenatal treatment with IVIG and/or corticosteroids recommended to prevent severe thrombocytopenia and intracranial hemorrhage in subsequent pregnancies 135.
Pediatrics: Rapid postnatal intervention crucial to prevent neurologic sequelae 134.Key Recommendations
Antenatal administration of high-dose intravenous immunoglobulin (1-2 g/kg weekly) to mothers with a history of NAIT significantly reduces the risk of intracranial hemorrhage and improves neonatal outcomes (Evidence: Strong 15).
Consider antenatal corticosteroid therapy in conjunction with IVIG for enhanced platelet count elevation (Evidence: Moderate 1).
Perform regular antenatal ultrasound monitoring for signs of intracranial hemorrhage in pregnancies at risk for NAIT (Evidence: Moderate 4).
Deliver affected infants via cesarean section to minimize delivery-related trauma and promptly initiate postnatal treatment (Evidence: Expert opinion 1).References
1 Sharif U, Kuban K. Prenatal intracranial hemorrhage and neurologic complications in alloimmune thrombocytopenia. Journal of child neurology 2001. link
2 Pearlman SA, Meek RS, Cowchock FS, Smith JB, McFarland J, Aster RH. Neonatal alloimmune thrombocytopenia after maternal immunization with paternal mononuclear cells: successful treatment with intravenous gamma globulin. American journal of perinatology 1992. link
3 Kaplan C, Morel-Kopp MC, Kroll H, Kiefel V, Schlegel N, Chesnel N et al.. HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. British journal of haematology 1991. link
4 Burrows RF, Caco CC, Kelton JG. Neonatal alloimmune thrombocytopenia: spontaneous in utero intracranial hemorrhage. American journal of hematology 1988. link
5 Bussel JB, Berkowitz RL, McFarland JG, Lynch L, Chitkara U. Antenatal treatment of neonatal alloimmune thrombocytopenia. The New England journal of medicine 1988. link